Dipl.-Ing. Dr. Stephan Harm

Danube University Krems

Stephan Harm

Dipl.-Ing. Dr. Stephan Harm

Center for Biomedical Technology

Publications (Extract Research Database)

Harm, S.; Lohner, K.; Fichtinger, U.; Schildböck, C.; Zottl, J.; Hartmann, J. (2019). Blood Compatibility—An Important but Often Forgotten Aspect of the Characterization of Antimicrobial Peptides for Clinical Application. International Journal of Molecular Sciences, Volume 20 Issue 21 10.3390/ijms20215426: 10.3390/ijms20215426

Harm, S.; Schildböck, C.; Hartmann, J. (2019). Cytokine removal in extracorporeal blood purification: An in vitro study. Blood Purification, in press: 1-11

Gubensek, J.; Strobl, K.; Harm, S.; Weiss, R.; Eichhorn, T.; Buturovic-Ponikvar, J.; Weber, V.; Hartmann, J. (2018). Influence of citrate concentration on the activation of blood cells in an in vitro dialysis setup. PLoS ONE, 13(6):e0199204: doi: 10.1371/journal.pone.0199204

Harm, S.; Schildböck, C.; Hartmann, J. (2018). Removal of stabilizers from human serum albumin by adsorbents and dialysis used in blood purification. PLoS One, Jan 24;13(1): 10.1371/journal.pone.0191741

Eichhorn, T.; Hartmann, J.; Harm, S.; Linsberger, I.; König, F.; Valicek, G.; Miestinger, G.; Hörmann, C.; Weber, V. (2017). Clearance of selected cytokines with continuous veno-venous hemodialysis using Ultraflux EMiC2 versus Ultraflux AV1000S. Blood Purification, 44(4): 260-266

Hartmann, J.; Harm, S. (2017). A new integrated technique for the supportive treatment of sepsis. International Journal of Artificial Organs, 40(1): 4-8

Hartmann, J.; Harm, S. (2017). Removal of bile acids by extracorporeal therapies: an in vitro study. International Journal of Artificial Organs, doi: 10.5301/ijao.5000643: doi: 10.5301/ijao.5000643

Strobl, K.; Harm, S.; Weber, V.; Hartmann, J. (2017). The role of ionized calcium and magnesium in regional citrate anticoagulation and its impact on inflammatory parameters. International Journal of Artificial Organs, 40(1): 15-21

Harm, S.; Hartmann, J. (2017). Removal of stabilizers from human serum albumin by nanostructured adsorbents. BioNanoMed Congress, March 2017, Krems, Austria

Hartmann, J.; Harm, S. (2017). Cytokine induction in human blood by fractionated bacterial lysates. BioNanoMed Congress, March 2017, Krems, Austria

Harm, S.; Gabor, F.; Hartmann, J. (2016). Low-Dose Polymyxin: an Option for Therapy of Gram-Negative Sepsis. Innate Immunity, 2016: 274-283

Harm, S.; Gruber, A.; Gabor, F.; Hartmann, J. (2016). Adsorption of Selected Antibiotics to Resins in Extracorporeal Blood Purification. Blood Purification, 2016(41): 55-63

Harm, S.; Hartmann, J. (2016). Polymyxin-Coated Nanostructured Materials: An Option for Sepsis Treatment. Journal of Nanomaterials & Molecular Nanotechnology, 10.4172/2324-8777.S4-003

Harm, S.; Gabor, F.; Hartmann, J. (2015). In vitro characterization of a new adsorbent for cytokines in extracorporeal blood purification. Shock, 44 Suppl 2:9

Harm, S.; Gabor, F.; Hartmann, J. (2015). Characterization of Adsorbents for Cytokine Removal from Blood in an In Vitro Model. Journal of Immunology Research, Vol. 2015, Article ID 484736

Harm S., Falkenhagen D., Hartmann J. (2014). Endotoxin adsorbents in extracorporeal blood purification: Do they fulfill expectations? The International journal of artificial organs, 04/2014, 37(3), DOI:10.5301/ijao.5000304: 222

Harm S.; Falkenhagen D.; Hartmann J. (2014). Endotoxin Adsorbents in Extracorporeal Blood Purification – Do They Fulfill The Expectations? Int J Art Org, Vol. 37, Issue 3: 222-232

Harm, S.; Falkenhagen, D.; Hartmann, J. (2014). Pore size – a key property for selective toxin removal in blood purification. Int J Art Org, DOI:10.5301/ijao.5000354: 668-678

Hartmann, J.; Beyer, R.; Harm, S. (2014). Effective Removal of Estrogens from Drinking Water and Wastewater by Adsorption Technology. Environmental Processes, 2014, 1: 87-94

Tripisciano, C.; Eichhorn, T.; Harm, S.; Weber, V. (2014). Adsorption of the Inflammatory Mediator High Mobility Group Box 1 by Polymers with Different Charge and Porosity. BioMed Research International, Article ID 238160

Load more
from

Patents (Extract Research Database)

Dosing instructions for endotoxin-binding lipopeptides

Center for Biomedical Technology

Patent-Nr: WO2014001444A1, Status: Erteilung

Ass.Prof. Dr. Jens Hartmann, Dipl.-Ing. Dr. Martin Brandl, Dipl.-Ing. Dr. Stephan Harm

Back to top

 

To Glossary

This website uses cookies to improve your user experience, for analytical purposes for optimizing our systems and for marketing purposes. By clicking on „OK" or continuing to browse the site, you are agreeing to the use of cookies. More information concerning privacy policy and data protection official.

OK